Appeals Court Preserves False Claims Act Whistleblower Suits in Unanimous Ruling

A unanimous panel reversed the constitutional ruling

ATLANTA — A federal appeals court ruled unanimously September 1 that private whistleblowers may continue filing False Claims Act lawsuits on behalf of the United States, reversing a trial judge who had found the arrangement unconstitutional.

The Eleventh Circuit held that a person who brings a so-called qui tam action is not an officer of the United States who must be formally appointed under Article II. The panel said a relator lacks a continuing position established by federal law and instead pursues a particular case under powers Congress defined.

The decision restores the lawsuit brought by Clarissa Zafirov against Florida health-care organizations. It does not decide whether the defendants submitted false Medicare claims; those allegations remain contested and return to the lower court.

What qui tam litigation actually does

The False Claims Act allows the federal government to seek damages and civil penalties when a person knowingly submits false claims for public money. Its qui tam provisions also allow a private relator with information about suspected fraud to file in the government's name.

The Justice Department receives the complaint under seal and may investigate before deciding whether to intervene. Even when the government declines, the relator may sometimes continue, subject to statutory controls. A successful relator generally receives 15 percent to 30 percent of the recovery, depending on the government's role and other factors.

That financial incentive is controversial, but it is not a secret bounty created by a court. Congress wrote it into 31 U.S.C. Section 3730 as part of an enforcement system whose roots extend to the Civil War era.

The panel rejected the Appointments Clause theory

The district court had reasoned that a relator exercises significant federal enforcement power and therefore must be appointed like an executive-branch officer. The appellate panel rejected that premise because a relator does not occupy an ongoing federal office and cannot launch a portfolio of cases for the government.

The opinion also emphasized the government's continuing statutory authority, including its ability to intervene, seek dismissal and limit a relator's participation. Those controls helped explain why the lawsuit does not convert a private plaintiff into an unappointed federal prosecutor.

The ruling aligns the Eleventh Circuit with earlier appellate decisions that sustained qui tam litigation. Recent separate opinions by several Supreme Court justices had renewed debate, however, so the constitutional question may still attract further review.

The Medicare allegations remain unproven

Zafirov alleges that the defendants improperly coded medical conditions in Medicare Advantage records, causing the government to pay more than it should have. The defendants deny wrongdoing and had won dismissal on the constitutional issue before the factual claims were fully adjudicated.

Reinstating a complaint is not the same as finding fraud. The parties may contest evidence, legal elements, damages and defenses in later proceedings, and the Justice Department's support for the statute does not establish liability in this particular case.

Precise reporting therefore separates two outcomes: the whistleblower mechanism survived this appeal, while the underlying payment allegations remain allegations.

Why the ruling matters beyond one lawsuit

False Claims Act cases touch health care, defense contracting, disaster programs and other areas where private entities receive federal money. Invalidating qui tam suits across a large appellate region could have disrupted investigations and recoveries built around insider information.

The decision instead keeps that channel open in Alabama, Florida and Georgia. It also gives other courts a fresh appellate analysis as defendants continue testing the statute against modern separation-of-powers doctrine.

For taxpayers, the central accountability question is not whether every whistleblower is correct. It is whether credible allegations can be examined under rules that protect due process while allowing the government to recover money obtained through proven fraud.

Limits and what to watch

The ruling resolves the Appointments Clause issue for this appeal, but it does not prove the Medicare-fraud allegations, prevent further review or guarantee that the whistleblower will recover money.

The next development to watch is proceedings in the Middle District of Florida and any request for rehearing or Supreme Court review.